A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck — PARSPORT-II

Oropharyngeal Squamous Cell Cancer Clinical Trial

Official title:
A Phase II Study of Parotid-gland Sparing Intensity-modulated Radiotherapy in Patients With Midline Tumour of the Head and Neck

Status Completed

Clinical Trial Summary

This study is a phase II trial designed to test the feasibility of delivering IMRT to head and neck cancer patients with tumours arising in the midline (oropharynx and hypopharynx), and to assess possible improvement in reducing the incidence of xerostomia with bilateral superficial lobe parotid sparing IMRT.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Carcinoma, Squamous Cell
Head and Neck Neoplasms
Hypopharyngeal Squamous Cell Cancer
Neoplasms, Squamous Cell
Oropharyngeal Squamous Cell Cancer

Clinical Trial Details

NCT number	NCT02149602
Study type	Observational
Source	Royal Marsden NHS Foundation Trust
Contact
Status	Completed
Phase	N/A
Start date	July 2005
Completion date	January 2014

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02784288` - Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer	Phase 2